ARCHIVES

ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 33 No. 29 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

DCBDC board Okays RFA concept On AIDS Lymphoma

March 26, 1993

In Brief: Mauer to Leave St. Jude For U. Tennessee As Cancer Program Director; Harvard, MIT Share ACS Award

July 29, 1983

Judge Hears Arguments In Fisher’s Privacy Act Suit Over Databases

January 19, 1996

NCCS Networker Volume 9 Issue 1, Spring 1995

April 13, 1995

Scientists Falsified Research, ORI Says

July 5, 1996

RFA: Clinical Correlative Studies In Solid Tumors

April 3, 1992